Mode
Text Size
Log in / Sign up
N/A N=474 Randomized Double-blind Other

The Use of Public Messaging for the Promotion of Firearm Safety to Veterans

Injuries

Enrolled (actual)
474
Serious AEs
0.0%
Results posted
Aug 2020
Primary outcome: Primary: Number of Participants With Self-reported Injury Prevention Belief — 66; 73; 57; 49 Participants

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Exposure to firearm safety PSA (Other); Exposure to health promotion PSA (Other)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Canandaigua VA Medical Center
Primary completion
Mar 2020

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Participants With Self-reported Injury Prevention Belief
71; 79; 64; 44; 54; 46
PRIMARY
Number of Participants With Self-reported Injury Prevention Belief
71; 79; 64; 44; 54; 46
SECONDARY
Number of Participants Who Self-reported Firearm Storage Behavior at Baseline
8; 23; 24; 56; 48; 36
SECONDARY
Number of Participants Who Self-reported Firearm Storage Behavior at Exit
7; 25; 23; 57; 46; 37

Summary

This pilot study seeks to determine if exposure to the firearm safety public service announcement (PSA) developed by the U.S. Department of Veterans Affairs (VA) is associated with changes in related beliefs and safe storage practices. Participants are randomly assigned to message exposure or control conditions. Data from this project will inform injury prevention outreach efforts targeted towards Veteran populations.

Eligibility Criteria

Inclusion Criteria

  • Veterans of all gender/sex, race/ethnicities
  • Living in United States
  • Fluent in English language
  • Capable of understanding the goals of the study
  • Possess computer/internet access

Exclusion Criteria

  • Not a U.S. Veteran living in the United States
  • Determined to be cognitively impaired
  • Currently institutionalized (e.g., hospitalized; incarcerated, etc.)
  • Do not possess computer/internet access
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03417752). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search